JP7620382B2 - Glutathione stress resistant yeast - Google Patents
Glutathione stress resistant yeast Download PDFInfo
- Publication number
- JP7620382B2 JP7620382B2 JP2018109210A JP2018109210A JP7620382B2 JP 7620382 B2 JP7620382 B2 JP 7620382B2 JP 2018109210 A JP2018109210 A JP 2018109210A JP 2018109210 A JP2018109210 A JP 2018109210A JP 7620382 B2 JP7620382 B2 JP 7620382B2
- Authority
- JP
- Japan
- Prior art keywords
- glutathione
- yeast
- amino acid
- acid sequence
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Description
本発明は、グルタチオンストレスに対する耐性を付与させた酵母を育種する方法に関する。 The present invention relates to a method for breeding yeast that is resistant to glutathione stress.
グルタチオンはグルタミン酸、システイン、グリシンから構成されるトリペプチドで、例えば大腸菌からヒトに至るまで広く保存された生理活性分子である。
グルタチオンは抗酸化作用、免疫賦活作用、解毒・肝機能改善作用、等の様々な機能性を発揮することから、医薬品、食品、化粧品の分野で注目されている(特許文献1)。
細胞におけるグルタチオンの機能は、鉄硫黄クラスタータンパク質の構成と成熟化、活性酸素種の消去、アミノ酸代謝、酸化還元バランスの恒常性維持によるタンパク質のフォールディング、等多岐に渡る(非特許文献1)。
Glutathione is a tripeptide consisting of glutamic acid, cysteine, and glycine, and is a biologically active molecule that is widely conserved, for example, from Escherichia coli to humans.
Glutathione has attracted attention in the fields of medicine, food and cosmetics because it exhibits various functionalities such as antioxidant activity, immunostimulating activity, detoxification and liver function improving activity (Patent Document 1).
The functions of glutathione in cells are diverse, including the formation and maturation of iron-sulfur cluster proteins, elimination of reactive oxygen species, amino acid metabolism, and protein folding through homeostasis of redox balance (Non-Patent Document 1).
近年のライブセルイメージング技術の発展に伴い、還元型グルタチオンと酸化型グルタチオンの量比がオルガネラごとに大きく異なり、グルタチオンの空間的バランスが高度に制御されていることが明らかになってきた。還元型グルタチオンと酸化型グルタチオンの量比は、例えば細胞質やミトコンドリア内膜では3,000:1だが、小胞体では3:1~1:1との報告がある(非特許文献2)。小胞体が酸化的環境にシフトしているのは、グルタチオンを介したプロテインジスルフィドイソメラーゼ等の働きで分泌タンパク質や膜タンパク質を正しくフォールディングさせるためである(非特許文献1)。 With the recent development of live cell imaging technology, it has become clear that the ratio of reduced glutathione to oxidized glutathione varies greatly from organelle to organelle, and that the spatial balance of glutathione is highly regulated. For example, the ratio of reduced glutathione to oxidized glutathione is 3,000:1 in the cytoplasm and mitochondrial inner membrane, but it has been reported that it is 3:1 to 1:1 in the endoplasmic reticulum (Non-Patent Document 2). The reason why the endoplasmic reticulum shifts to an oxidative environment is that secretory proteins and membrane proteins are properly folded by the action of protein disulfide isomerase and the like via glutathione (Non-Patent Document 1).
現在グルタチオンの工業的生産法は酵母を用いた発酵法が主流で、グルタチオンは酵母の細胞内に蓄積される。上述のようなグルタチオンの高い生理活性は、蓄積度合が過剰だと細胞毒性(グルタチオンストレス)があらわれることが知られていた(非特許文献3)。
それゆえに、グルタチオンストレスを低減するために、グルタチオンを積極的に液胞に輸送させることで、グルタチオン蓄積量と増殖性を同時改善させた報告(特許文献2)、また細胞毒性を回避するためにグルタチオンを細胞外(培地中)へ排出させ、グルタチオンの生産性を向上させた報告(非特許文献4)が存在する。
またグルタチオンの細胞毒性に関して更に詳細には、酵母内でのグルタチオンの過剰蓄積が、小胞体におけるタンパク質フォールディングやミトコンドリア活性に悪影響を及ぼすことが報告されている(非特許文献1)。
Currently, the mainstream industrial production method for glutathione is the fermentation method using yeast, and glutathione accumulates in yeast cells. It is known that the high physiological activity of glutathione as described above causes cytotoxicity (glutathione stress) when the degree of accumulation is excessive (Non-Patent Document 3).
Therefore, there is a report that, in order to reduce glutathione stress, glutathione was actively transported to the vacuole, thereby simultaneously improving glutathione accumulation and proliferation (Patent Document 2), and there is also a report that glutathione was excreted outside the cell (into the culture medium) to avoid cytotoxicity, thereby improving glutathione productivity (Non-Patent Document 4).
Regarding the cytotoxicity of glutathione in more detail, it has been reported that excessive accumulation of glutathione in yeast adversely affects protein folding in the endoplasmic reticulum and mitochondrial activity (Non-Patent Document 1).
しかしながらグルタチオンの細胞毒性に対して、耐性を付与させる因子は酵母に限らずあらゆる生物種でこれまで知られてない。従ってグルタチオンストレス耐性酵母の作出を通じたグルタチオンの生産性向上といった試みも未完である。 However, factors that confer resistance to the cytotoxicity of glutathione have not been known in yeast or any other organisms. Therefore, attempts to improve glutathione productivity through the creation of glutathione stress-resistant yeast remain incomplete.
上記背景技術を鑑み、本発明は
i)グルタチオンストレス耐性を酵母に付与させる因子を特定すること
および
ii)酵母にグルタチオンストレス耐性を付与する生物学的プロセスを特定すること、
を含むグルタチオン高生産酵母の製造方法を提供することを課題とする。
In view of the above background, the present invention aims to: i) identify a factor that confers glutathione stress resistance to yeast; and ii) identify a biological process that confers glutathione stress resistance to yeast.
The objective of the present invention is to provide a method for producing a high-yield glutathione-producing yeast comprising the steps of:
上述の課題を解決すべく、発明者らは酵母染色体マルチコピーライブラリーを用いて、多コピーでグルタチオンストレスを抑圧する遺伝子を探索した結果、グリコーゲンシンターゼキナーゼRim11をコードする遺伝子RIM11、14-3-3タンパク質Bmh1をコードする遺伝子BMH1、および細胞分裂G1期を下方調整するタンパク質Whi2をコードする遺伝子WHI2を見出すことができた。
さらに本発明者らはRNAシーケンス法を実施した結果、これらの遺伝子の強発現化が酵母にグルタチオンストレス耐性を付与させた要因が下記(a)、(b)の生物学的プロセスの変化であることを確認した。
(a)MAPK(Mitogen activated-protein kinase)経路の活性化
(b)減数分裂段階への移行
加えて本発明者らは(a)MAPK経路の下流で機能するグリコーゲンシンターゼキナーゼRim11に着目した。Rim11がリン酸化する基質として既知なUme6、ならびに該Ume6と協調するRpd3とSin3が、酵母にグルタチオンストレス耐性を付与する際に機能していることを、分子遺伝学的手法を用いて新規に見出した。本結果から、(a)MAPK経路に引き続き、エピジェネティクス機構の調整が、酵母にグルタチオンストレス耐性を付与させる要因あると結論付けるに至った。
In order to solve the above-mentioned problems, the inventors used a yeast chromosomal multicopy library to search for genes that suppress glutathione stress in multiple copies. As a result, they were able to find the gene RIM11 encoding the glycogen synthase kinase Rim11, the gene BMH1 encoding the 14-3-3 protein Bmh1, and the gene WHI2 encoding the protein Whi2, which down-regulates the G1 phase of cell division.
Furthermore, the inventors performed RNA sequencing and confirmed that the factor that endows yeast with glutathione stress resistance through increased expression of these genes is the change in the biological processes (a) and (b) below.
(a) Activation of the MAPK (Mitogen activated-protein kinase) pathway (b) Transition to the meiotic stage In addition, the present inventors focused on (a) glycogen synthase kinase Rim11, which functions downstream of the MAPK pathway. Using molecular genetic techniques, it was newly discovered that Ume6, known as a substrate phosphorylated by Rim11, and Rpd3 and Sin3, which cooperate with Ume6, function in conferring glutathione stress resistance to yeast. From this result, it was concluded that (a) the MAPK pathway, followed by the regulation of the epigenetic mechanism, is a factor in conferring glutathione stress resistance to yeast.
すなわち本発明は、
(1)下記(a)、(b)または(c)の生物学的プロセスに属する遺伝子で親株を形質転換して得られる、親株と比べてグルタチオンストレス耐性の向上した酵母。
(a)Mitogen activated-protein kinase(MAPK)経路
(b)減数分裂
(c)エピジェネティクス機構
(2)下記(A)~(C)のいずれかのアミノ酸配列をコードするDNAで親株を形質転換して得られる、親株と比べてグルタチオンストレス耐性の向上した酵母。
(A)配列番号1のアミノ酸配列と65%以上の相同性を有するアミノ酸配列
(B)配列番号2のアミノ酸配列と65%以上の相同性を有するアミノ酸配列
(C)配列番号3のアミノ酸配列と65%以上の相同性を有するアミノ酸配列
(3)前記(2)記載の酵母であって、かつ配列番号7のアミノ酸配列と65%以上の相同性を有するアミノ酸配列をコードするDNAで親株を形質転換して得られる酵母である、親株と比べてグルタチオンストレス耐性の向上した酵母。
(4)(a)MAPK経路の下流で機能する生物学的プロセスであって、細胞分裂段階を外部の生育環境変化に応答して適宜、体細胞分裂または減数分裂、あるいは分裂の一時停止期(G1停止, G2停止)に移行させる下記(I)の機構に属する遺伝子で親株を形質転換して得られる、親株と比べてグルタチオンストレス耐性の向上した酵母。
(I)エピジェネティクス機構
(5)下記(D)~(F)のいずれかのアミノ酸配列をコードするDNAで親株を形質転換して得られる、親株と比べてグルタチオンストレス耐性の向上した酵母。
(D)配列番号33のアミノ酸配列と65%以上の相同性を有するアミノ酸配列
(E)配列番号34のアミノ酸配列と65%以上の相同性を有するアミノ酸配列
(F)配列番号35のアミノ酸配列と65%以上の相同性を有するアミノ酸配列
(6)前記(1)~(5)のいずれかに記載の酵母を培養する工程を含む、グルタチオンの製造方法。
に係るものである。
That is, the present invention provides:
(1) A yeast having improved glutathione stress resistance compared to a parent strain, which is obtained by transforming a parent strain with a gene belonging to the following biological process (a), (b) or (c):
(a) Mitogen activated-protein kinase (MAPK) pathway (b) meiosis (c) epigenetic mechanism
(2) A yeast having improved glutathione stress resistance compared to a parent strain, obtained by transforming a parent strain with DNA encoding any one of the following amino acid sequences (A) to (C):
(A) an amino acid sequence having 65% or more homology with the amino acid sequence of SEQ ID NO:1; (B) an amino acid sequence having 65% or more homology with the amino acid sequence of SEQ ID NO:2; (C) an amino acid sequence having 65% or more homology with the amino acid sequence of SEQ ID NO:3.
(3) A yeast according to (2) above, which is obtained by transforming a parent strain with DNA encoding an amino acid sequence having 65% or more homology to the amino acid sequence of SEQ ID NO:7, and which has improved glutathione stress resistance compared to the parent strain.
(4) (a) A yeast having improved glutathione stress resistance compared to a parent strain, obtained by transforming a parent strain with a gene belonging to the mechanism (I) below, which is a biological process that functions downstream of the MAPK pathway and transitions the cell division stage to somatic cell division, meiosis, or a pause in division (G1 arrest, G2 arrest) as appropriate in response to a change in the external growth environment.
(I) Epigenetic mechanisms
(5) A yeast having improved glutathione stress resistance compared to a parent strain, obtained by transforming a parent strain with DNA encoding any one of the following amino acid sequences (D) to (F):
(D) an amino acid sequence having 65% or more homology with the amino acid sequence of SEQ ID NO: 33; (E) an amino acid sequence having 65% or more homology with the amino acid sequence of SEQ ID NO: 34; (F) an amino acid sequence having 65% or more homology with the amino acid sequence of SEQ ID NO: 35
(6) A method for producing glutathione, comprising a step of culturing the yeast according to any one of (1) to (5).
This relates to:
本発明の方法によれば、酵母細胞内におけるグルタチオンの高蓄積によって誘導される細胞毒性に対して、宿主酵母にグルタチオンストレス耐性を獲得させることができる。当該形質を獲得させた酵母を育種することでグルタチオン高生産酵母を製造することができる。
本発明により得られたグルタチオン高生産酵母は、グルタチオンを高含有しながらも増殖性が野生型のそれと同等レベルにあるので、グルタチオンの工業的生産において、その生産性向上に寄与することが期待される。
According to the method of the present invention, it is possible to impart glutathione stress resistance to a host yeast against cytotoxicity induced by high accumulation of glutathione in yeast cells. By breeding the yeast that has acquired this trait, it is possible to produce a glutathione hyper-producing yeast.
The glutathione-rich yeast obtained according to the present invention has a proliferation rate equivalent to that of the wild type while containing a high amount of glutathione, and is therefore expected to contribute to improving the productivity in the industrial production of glutathione.
以下、本発明を詳細に説明する。
本発明は、グリコーゲンシンターゼキナーゼRim11(配列番号1)、14-3-3タンパク質Bmh1(配列番号2)、並びに体細胞分裂G1期の下方調整因子Whi2(配列番号3)、各々をコードする遺伝子、具体的にはそれぞれRIM11(配列番号4)、BMH1(配列番号5)、WHI2(配列番号6)が酵母にグルタチオンストレス耐性を付与することを新規に見出したものである。本発明によれば、これらいずれかの遺伝子発現量を上方調整させ、当該タンパク質の産生を増量させることで酵母にグルタチオンストレス耐性を付与させることができる。特に好ましくはRim11、次に好ましくはBmh1をそれぞれコードする遺伝子の発現向上である。
The present invention will be described in detail below.
The present invention has newly discovered that genes encoding glycogen synthase kinase Rim11 (SEQ ID NO: 1), 14-3-3 protein Bmh1 (SEQ ID NO: 2), and somatic cell division G1 phase down-regulator Whi2 (SEQ ID NO: 3), specifically RIM11 (SEQ ID NO: 4), BMH1 (SEQ ID NO: 5), and WHI2 (SEQ ID NO: 6), confer glutathione stress resistance to yeast. According to the present invention, glutathione stress resistance can be imparted to yeast by upregulating the expression level of any of these genes and increasing the production of the protein. Particularly preferred is the improvement of expression of the gene encoding Rim11, and secondly preferred is the improvement of expression of the gene encoding Bmh1.
大量産生させたグリコーゲンシンターゼキナーゼあるいは14-3-3タンパク質、あるいは体細胞分裂G1期制御因子がグルタチオンストレス耐性を付与することは酵母をはじめあらゆる生物種でこれまで知られてない。
グリコーゲンシンターゼキナーゼの既知機能、例えば細胞分裂の制御や酸化ストレス応答(非特許文献7)、あるいは14-3-3タンパク質の既知機能、例えばMAPK経路の調節(非特許文献5)、あるいは細胞分裂制御因子の既知機能、例えば体細胞分裂G1期のチェックポイント(非特許文献6)と、非特許文献1が報告するグルタチオンストレスの作用機序、即ちミトコンドリア内在性酵素の活性低下や小胞体ストレス誘導、とは細胞生理学的に直接的に結びつくものではない。
It has not been known so far that mass-produced glycogen synthase kinase, 14-3-3 protein, or somatic cell division G1 phase regulators confer glutathione stress resistance in any organism, including yeast.
The known functions of glycogen synthase kinase, such as the control of cell division and oxidative stress response (Non-Patent Document 7), the known functions of 14-3-3 proteins, such as the regulation of the MAPK pathway (Non-Patent Document 5), or the known functions of cell division control factors, such as the checkpoint in the G1 phase of somatic cell division (Non-Patent Document 6), are not directly linked in terms of cell physiology to the mechanism of action of glutathione stress reported in Non-Patent Document 1, i.e., a decrease in the activity of endogenous mitochondrial enzymes and induction of endoplasmic reticulum stress.
本発明は、さらにトランスクリプトーム解析により見出された、酵母のグルタチオンストレス耐性機構の作用機序に関するものである。
グリコーゲンシンターゼキナーゼファミリーの一員であるRIM11遺伝子は、窒素飢餓に応答したTor経路と、引き続き起こるMAPK経路(分裂促進因子活性化タンパク質キナーゼ)を通じて活性化されることが知られている(非特許文献8)。またRim11は初期減数分裂期において、減数分裂開始因子(Initiator of Meiosis,IME)であるIme1とIme2の制御に関与し、細胞の減数分裂フェーズへの移行を正に誘導することが報告されている(非特許文献9)。しかしながらRIM11のこれら機能と、GSHストレスの作用機序とは容易に結びつくものではない。
The present invention further relates to the mechanism of action of the glutathione stress resistance mechanism in yeast, which was discovered by transcriptome analysis.
The RIM11 gene, a member of the glycogen synthase kinase family, is known to be activated through the Tor pathway in response to nitrogen starvation and the subsequent MAPK pathway (mitogen-activated protein kinase) (Non-Patent Document 8). It has also been reported that Rim11 is involved in the control of the meiosis initiators Ime1 and Ime2 (IME) during early meiosis, and positively induces the transition of cells to the meiosis phase (Non-Patent Document 9). However, these functions of RIM11 are not easily linked to the mechanism of action of GSH stress.
そこでRIM11強発現酵母のRNAシーケンス解析を実施したが、意外なことに、酵母にグルタチオンストレス耐性を付与させる生物学的プロセスとして、MAPK経路の亢進と体細胞分裂から減数分裂フェーズへの移行、が確認された。Rim11の基質にはUme6が報告されており、加えてUme6と協調するタンパク質としてRpd3とSin3がある。Ume6、Rpd3、Sin3はヒストン脱アセチル化酵素複合体(Conserved Histone Deacetylase;HDAC)を構成し、環境変化に応答して遺伝子発現のタイミングを制御するエピジェネティクス機構の調整因子であることが知られている(非特許文献12)
エピジェネティクス機構とグルタチオンの生理機能(酸化還元バランス維持、抗酸化能、解毒作用、およびグルタチオンストレス)とは、既知情報からは両者の関連性が見出せない。
しかしながら本発明者らは酵母の分子遺伝学的手法を用いることで、両機構に遺伝的相互作用が存在することを見出すに至った。当該関連性についても容易に推察できるものではなく、本知見を活かしたグルタチオンの高効率生産が産業的に資する効果は大きい。
上述の酵母染色体マルチコピーライブラリースクリーニングより、RIM11と同時に14-3-3タンパク質遺伝子BMH1が選抜されたが、興味深いことにBmh1も、Torシグナル経路下流のMAPK経路で機能することが知られている(非特許文献6)。以上の結果は、MAPK経路が酵母にグルタチオンストレス耐性を付与させていることを裏付けるものである。
Therefore, we performed RNA sequencing analysis of yeast with strong RIM11 expression, and unexpectedly, we confirmed that the biological process that confers glutathione stress resistance to yeast is the enhancement of the MAPK pathway and the transition from somatic cell division to the meiotic phase. Ume6 has been reported as a substrate of Rim11, and in addition, Rpd3 and Sin3 are proteins that cooperate with Ume6. Ume6, Rpd3, and Sin3 constitute a histone deacetylase complex (Conserved Histone Deacetylase; HDAC), and are known to be regulators of the epigenetic mechanism that controls the timing of gene expression in response to environmental changes (Non-Patent Document 12).
No relationship between epigenetic mechanisms and the physiological functions of glutathione (maintenance of redox balance, antioxidant activity, detoxification, and glutathione stress) can be found from existing information.
However, by using a molecular genetic technique in yeast, the inventors have discovered that there is a genetic interaction between the two mechanisms. This relationship is not something that can be easily predicted, and highly efficient production of glutathione based on this finding will have a great industrial impact.
From the above yeast chromosomal multicopy library screening, the 14-3-3 protein gene BMH1 was selected at the same time as RIM11, and interestingly, Bmh1 is also known to function in the MAPK pathway downstream of the Tor signal pathway (Non-Patent Document 6). The above results support the idea that the MAPK pathway confers glutathione stress resistance to yeast.
また窒素飢餓応答によって体細胞分裂G1期が停滞し、サイクリンタンパク質Cln3とCln2が抑制されることが知られている。Cln2はIme1の負のレギュレーターであるから、Cln2の機能が低下するとIME1遺伝子がアップレギュレーションされ、減数分裂フェーズへの移行が促進される(非特許文献9)。酵母染色体マルチコピーライブラリースクリーニングでWhi2をコードする遺伝子WHI2が見出されたが、当該タンパク質はCln1とCln2を下方調整するため(非特許文献7)、IME1遺伝子の発現が上方調整され、減数分裂段階への移行が促進されるだろう。以上の結果は、減数分裂段階への移行が、酵母にグルタチオンストレス耐性を付与させる要因である可能性が考えられる。
以上の生物学的プロセスを図1に描画した。
It is also known that the nitrogen starvation response causes the G1 phase of somatic cell division to stagnate, and the cyclin proteins Cln3 and Cln2 are suppressed. Cln2 is a negative regulator of Ime1, so when Cln2 function is reduced, the IME1 gene is upregulated, promoting the transition to the meiotic phase (Non-Patent Document 9). A gene encoding Whi2, WHI2, was found in a yeast chromosome multicopy library screening, and since this protein downregulates Cln1 and Cln2 (Non-Patent Document 7), the expression of the IME1 gene will be upregulated, promoting the transition to the meiotic phase. The above results suggest that the transition to the meiotic phase may be a factor that confers glutathione stress resistance to yeast.
The above biological processes are depicted in FIG.
また本発明はグルタチオンの生産性を向上させた酵母の製造方法に関する。
グリコーゲンシンターゼキナーゼであるRim11(配列番号1)をコードする遺伝子を大量発現させると、酵母においてグルタチオン含量を増大させることができる。該遺伝子のほか、14-3-3タンパク質であるBmh1(配列番号2)をコードする遺伝子、体細胞分裂G1期制御因子であるWhi2(配列番号3)をコードする遺伝子であってもよい。
The present invention also relates to a method for producing yeast having improved glutathione productivity.
The glutathione content in yeast can be increased by overexpressing a gene encoding glycogen synthase kinase Rim11 (SEQ ID NO: 1). In addition to this gene, a gene encoding a 14-3-3 protein Bmh1 (SEQ ID NO: 2) or a gene encoding a somatic cell division G1 phase regulator Whi2 (SEQ ID NO: 3) may also be used.
さらに、エピジェネティクス機構の調整因子であることが知られているUme6(配列番号33)、Rpd3(配列番号34)、Sin3(配列番号35)をコードする遺伝子でもよい。 Furthermore, the gene may be a gene encoding Ume6 (sequence number 33), Rpd3 (sequence number 34), or Sin3 (sequence number 35), which are known to be regulators of the epigenetic mechanism.
また、本発明では、配列番号1~3、33~35のアミノ酸配列と65%以上、好ましくは80%以上、さらに好ましくは90%以上の相同性を有するアミノ酸配列を発現させても良い。 In addition, in the present invention, an amino acid sequence having a homology of 65% or more, preferably 80% or more, and more preferably 90% or more with the amino acid sequences of SEQ ID NOs: 1 to 3 and 33 to 35 may be expressed.
またグルタチオン合成酵素-I(配列番号7)をコードする遺伝子GSH1(配列番号8)を強発現させた酵母で、更にRim11、Bmh1またはWhi2の遺伝子を過剰発現させると、グルタチオン含量を相乗的に増大させることができる。
これら方法に則り育種した酵母は、細胞内にグルタチオンを高含有するにもかかわらず、増殖性や菌体収量(単位糖重量あたりに取得される酵母菌体の重量、バイオマス)は野生型のそれと同等であることから、当該発明酵母はグルタチオン生産性の向上に期待できる。
Furthermore, when the Rim11, Bmh1 or Whi2 gene is overexpressed in a yeast in which the gene GSH1 (SEQ ID NO: 8) encoding glutathione synthetase-I (SEQ ID NO: 7) is strongly expressed, the glutathione content can be synergistically increased.
Yeast bred according to these methods has high intracellular glutathione content, yet its growth rate and cell yield (weight of yeast cells obtained per unit weight of sugar, biomass) are equivalent to those of the wild type, so the yeast of the invention is expected to improve glutathione productivity.
更に、既報のグルタチオン高生産方法、例えば酵母を培養する培地にシステインおよび/またはグリシンを添加する方法(特許文献3)、グルタチオンレダクターゼ遺伝子の破壊やグルタチオンペルオキシダーゼ遺伝子の強発現化を施した手法(特許文献4)、MET30遺伝子に変異を導入させる方法(特許文献5)、を本発明の酵母に施すことにより、より一層のグルタチオン含量の増大も期待される。 Furthermore, by applying previously reported methods for high glutathione production, such as adding cysteine and/or glycine to the medium in which yeast is cultured (Patent Document 3), a method of disrupting the glutathione reductase gene or enhancing the expression of the glutathione peroxidase gene (Patent Document 4), or a method of introducing a mutation into the MET30 gene (Patent Document 5), to the yeast of the present invention, it is expected that the glutathione content will be further increased.
<酵母の種類>
本発明に用いる酵母は特に制限はなく、例えばサッカロマイセス・セレビシエ(Saccharomyces cerevisiae)、サッカロマイセス・ルーキシー(Saccharomyces rouxii)、サッカロマイセス・フラギリス(Saccharomyces fragilis)などのサッカロマイセス属、キャンディダ・ユティリス(Candida utilis)、キャンディダ・トロピカリス(Candida tropicalis)、キャンディダ・グラブラータ(Candida glabrata)、キャンディダ・マルトーサ(Candida maltosa)などのキャンディダ属、ジゴサッカロマイセス・ルーキシー(Zygosaccharomyces rouxii)などのジゴサッカロマイセス属、などの酵母が挙げられる。
<Types of yeast>
The yeast used in the present invention is not particularly limited, and examples thereof include the genus Saccharomyces, such as Saccharomyces cerevisiae, Saccharomyces rouxii, and Saccharomyces fragilis; the genus Candida, such as Candida utilis, Candida tropicalis, Candida glabrata, and Candida maltosa; the genus Zygosaccharomyces rouxii; rouxii) and the like.
<遺伝子の大量発現方法>
Rim11をコードする遺伝子たとえばRIM11を大量発現させる方法は当業者に周知であり、例えば、当該遺伝子をコードする塩基配列から成るDNAを酵母で自己複製する多コピーベクター(例えば非特許文献10)にクローニングした発現プラスミドを用いる方法や、当該遺伝子の重複DNA断片を酵母ゲノムに組込んでコピー数を増加させる方法、あるいは当該遺伝子のプロモーターよりも強力なプロモーター制御下に該遺伝子を配置させることで発現量を上げる方法、等によって行うことができる。強力なプロモーターには、公知の高発現プロモーター、例えばPGK1、TDH3、TEF1、CYC1、などの遺伝子の上流プロモーター配列を挙げることができる。
<Method for overexpression of genes>
Methods for mass-expressing a gene encoding Rim11, such as RIM11, are well known to those skilled in the art, and can be carried out, for example, by using an expression plasmid in which DNA consisting of a base sequence encoding the gene is cloned into a multicopy vector (e.g., Non-Patent Document 10) that self-replicates in yeast, by integrating overlapping DNA fragments of the gene into the yeast genome to increase the copy number, or by placing the gene under the control of a promoter stronger than the promoter of the gene to increase the expression level, etc. Examples of strong promoters include upstream promoter sequences of known high expression promoters, such as PGK1, TDH3, TEF1, and CYC1 genes.
他にもニトロソグアニジンやエチルメタンスルフォネートなどの化学変異誘発剤処理、重粒子ビームや放射線、エックス線、UVなどの照射、あるいは亜硝酸等、通常の突然変異誘発操作を用いても当該遺伝子の強発現化は可能である。 In addition, it is also possible to enhance the expression of the gene using standard mutagenesis techniques, such as treatment with chemical mutagens such as nitrosoguanidine or ethyl methanesulfonate, exposure to heavy particle beams, radiation, X-rays, UV light, or nitrous acid.
<総グルタチオン含量の測定方法>
当該方法は当業者に周知であり、例えば Tietzeらの酵素を用いるレイトアッセイ(非特許文献11)や、高速液体クロマトグラフィー(HPLC)を用いる方法(特許文献6)、質量分析計を用いる方法(非特許文献1)などが挙げられる。市販品であればGSSG/GSH Quantification Kit(同仁化学研究所製)などが使用できる。なお、ここで云う総グルタチオン含量とは、還元型グルタチオン(GSH)の含量と酸化型グルタチオン(GSSG)の含量を合算したものである。
<Method for measuring total glutathione content>
The method is well known to those skilled in the art, and examples thereof include the enzyme-based rate assay by Tietze et al. (Non-Patent Document 11), a method using high performance liquid chromatography (HPLC) (Patent Document 6), and a method using a mass spectrometer (Non-Patent Document 1). Commercially available products such as GSSG/GSH Quantification Kit (manufactured by Dojindo Laboratories) can be used. The total glutathione content referred to here is the sum of the reduced glutathione (GSH) content and the oxidized glutathione (GSSG) content.
例えばTietzeらの方法に準ずるならば、当該改変酵母菌体を遠心分離機等で集菌し、水等で洗浄後、5-スルホサリチル酸水溶液に懸濁する。グルタチオンの抽出条件としては公知の方法、すなわち加熱抽出法や酵素分解法、あるいはガラスビーズやホモジナイザーを用いた物理的破砕法によっても可能である。但し酵母の培養状態の変遷に伴い細胞壁組成が変化し、特に定常期においては細胞壁溶解酵素の反応性が低下することが知られているので、酵素分解法は本製法では避けることが好ましい。抽出液を遠心分離機や膜ろ過に供することで清澄化し、適宜水あるいは5-スルホサリチル酸水溶液で希釈してグルタチオン抽出液を調製する。但しグルタチオンはpHが弱酸性の溶液でより安定なので、5-スルホサリチル酸水溶液を用いることがより好まれる。
抽出液中の総グルタチオン含量については、還元型グルタチオンがDTNB(5,5’-dithiobis-2-nitrobenzoic acid)を還元することにより生成するTNB(5-mercapto-2-nitrobenzoic acid)の吸光度OD420値の経時変化を追跡、測定することで求めることができる。
一方でGSH純品を5-スルホサリチル酸水溶液に溶解させたGSH標準溶液を調製し同水溶液で段階希釈する。上記DTNB反応と同時に得たOD420値とGSH濃度希釈系列の関係から、検量線を描画する。グルタチオン抽出液は、この検量線に基づくことで総グルタチオン濃度と含量を算出することが出来る。
For example, in accordance with the method of Tietze et al., the modified yeast cells are collected by a centrifuge or the like, washed with water or the like, and then suspended in an aqueous solution of 5-sulfosalicylic acid. Glutathione can be extracted by known methods, i.e., a heat extraction method, an enzymatic decomposition method, or a physical disruption method using glass beads or a homogenizer. However, since it is known that the composition of the cell wall changes with the transition of the culture state of yeast, and that the reactivity of cell wall-dissolving enzymes decreases, particularly in the stationary phase, it is preferable to avoid the enzymatic decomposition method in this production method. The extract is clarified by subjecting it to a centrifuge or membrane filtration, and appropriately diluted with water or an aqueous solution of 5-sulfosalicylic acid to prepare a glutathione extract. However, since glutathione is more stable in a solution with a weak acidic pH, it is more preferable to use an aqueous solution of 5-sulfosalicylic acid.
The total glutathione content in the extract can be determined by tracking and measuring the change over time in the absorbance OD 420 value of TNB (5-mercapto-2-nitrobenzoic acid) produced by reducing DTNB (5,5'-dithiobis-2-nitrobenzoic acid) with reduced glutathione.
On the other hand, a GSH standard solution is prepared by dissolving pure GSH in an aqueous solution of 5-sulfosalicylic acid, and then serially diluted with the same aqueous solution. A calibration curve is drawn from the relationship between the OD 420 value obtained simultaneously with the above DTNB reaction and the dilution series of GSH concentrations. The total glutathione concentration and content of the glutathione extract can be calculated based on this calibration curve.
尚、本発明においては、Tietzeらの方法である、グルタチオンレダクターゼ-DTNB法(以降「GR-DTNB法」)を用いた。
本発明におけるODは、分光光度計を用いて測定した値であり、具体的には分光光度計(レシオビーム分光光度計U-5100:日立ハイテクサイエンス社製)を用いて測定した。またpHは、pHメーターを用いて測定する。具体的には、pHメーターHM-30G(東亜ディーケーケー社製)を用いて測定した。なお総グルタチオンの分析では、吸光度OD420値をプレートリーダーで測定すると良く、具体的にはARVO X3 2030 Multilabel Reader(パーキンエルマー社製)を挙げる。
In the present invention, the glutathione reductase-DTNB method (hereinafter referred to as the "GR-DTNB method"), which is the method of Tietze et al., was used.
In the present invention, OD is a value measured using a spectrophotometer, specifically, a spectrophotometer (ratio beam spectrophotometer U-5100: manufactured by Hitachi High-Tech Science Corporation). pH is measured using a pH meter. Specifically, it was measured using a pH meter HM-30G (manufactured by DKK-TOA Corporation). In addition, in the analysis of total glutathione, it is preferable to measure the absorbance OD 420 value using a plate reader, specifically, an ARVO X3 2030 Multilabel Reader (manufactured by PerkinElmer Co., Ltd.).
酵母によるグルタチオン生産性を評価する際、酵母菌体の増殖性を調べるが、当該グルタチオンストレス耐性酵母の成長曲線は、Compact Rocking Incubator TVS062CA(アドバンテック社製)を使用して評価する。 When evaluating glutathione productivity by yeast, the proliferation of yeast cells is examined, and the growth curve of the glutathione stress-resistant yeast is evaluated using a Compact Rocking Incubator TVS062CA (manufactured by Advantec).
以下実施例を挙げて本発明を詳細に説明するが、これらに限定されるものではない。
[実施例1]
(1)グルタチオントランスポーターHGT1(OPT1)強発現用カセットの構築
サッカロマイセス・セレビシエBY4741(Mata his3Δ1 leu2Δ0 met15Δ0 ura3Δ0)のゲノムDNAを鋳型にして、二種類のプライマー(配列番号9と10)を用いてLEU2遺伝子をPCR増幅し、増幅物を制限酵素Spe I,Bam HIで消化した。この断片をプラスミドpBluescript SK-II(+)のSpe I,Bam HI消化部位に連結し、LEU2プラスミドを得た。
当該ゲノムDNAをテンプレートとし、二種類のプライマー(配列番号11と12)でTDH3遺伝子配列のプロモーター領域、すなわち開始コドン(ATG)のアデニンを+1塩基としたときの上流領域-680塩基から-1塩基までの塩基配列を増幅し、増幅物をBam HIとEco RIで消化した。この断片をLEU2プラスミドのBam HI、Eco RI消化部位に連結し、LEU2-TDH3prプラスミドを得た。
さらに当該ゲノムDNAをテンプレートとし、グルタチオントランスポーターHGT1(OPT1)遺伝子の翻訳領域(ORF)の一部を、二種類のプライマー(配列番号13と14)でPCR増幅し、増幅物をEco RIとSal Iで消化した。LEU2-TDH3prプラスミドのEco RIとSal I消化物に連結し、LEU2-TDH3pr-HGT1プラスミドを得た。
最後に当該ゲノムDNAをテンプレートとし、二種類のプライマー(配列番号15と16)でHGT1遺伝子配列のプロモーター領域の一部、すなわち上流領域-690塩基から-197塩基の塩基配列を増幅し、増幅物をSac IとSpe Iで消化した。この断片をLEU2-TDH3pr-HGT1プラスミドのSac I、Spe I消化部位に連結し、HGT1pr-LEU2-TDH3pr-HGT1プラスミドを構築した(図2)。
The present invention will be described in detail below with reference to examples, but is not limited to these.
[Example 1]
(1) Construction of a cassette for strong expression of glutathione transporter HGT1 (OPT1) Using the genomic DNA of Saccharomyces cerevisiae BY4741 (Mata his3Δ1 leu2Δ0 met15Δ0 ura3Δ0) as a template, the LEU2 gene was PCR amplified using two types of primers (SEQ ID NOs: 9 and 10), and the amplified product was digested with restriction enzymes Spe I and Bam HI. This fragment was ligated to the Spe I and Bam HI digestion sites of the plasmid pBluescript SK-II(+) to obtain the LEU2 plasmid.
Using the genomic DNA as a template, two types of primers (SEQ ID NOs: 11 and 12) were used to amplify the promoter region of the TDH3 gene sequence, i.e., the nucleotide sequence from -680 nucleotides to -1 nucleotide upstream of the adenine of the start codon (ATG) as +1 nucleotide, and the amplified product was digested with Bam HI and Eco RI. This fragment was ligated to the Bam HI and Eco RI digestion sites of the LEU2 plasmid to obtain the LEU2-TDH3pr plasmid.
Furthermore, using the genomic DNA as a template, a part of the open reading frame (ORF) of the glutathione transporter HGT1 (OPT1) gene was PCR amplified with two types of primers (SEQ ID NOs: 13 and 14), and the amplified product was digested with Eco RI and Sal I. This was ligated to the Eco RI and Sal I digestion product of the LEU2-TDH3pr plasmid to obtain the LEU2-TDH3pr-HGT1 plasmid.
Finally, using the genomic DNA as a template, a part of the promoter region of the HGT1 gene sequence, i.e., the nucleotide sequence from -690 nucleotides to -197 nucleotides in the upstream region, was amplified with two types of primers (SEQ ID NOs: 15 and 16), and the amplified product was digested with Sac I and Spe I. This fragment was ligated to the Sac I and Spe I digestion sites of the LEU2-TDH3pr-HGT1 plasmid to construct the HGT1pr-LEU2-TDH3pr-HGT1 plasmid (FIG. 2).
配列番号9
5’-ccggactagtaggagaacttctagtatatc-3’
配列番号10
5’-ccggggatcctttctgacagagtaaaattc-3’
配列番号11
5’-gccggatcccagttcgagtttatcattatc-3’
配列番号12
5’-ggccgaattctttgtttgtttatgtgtgtt-3’
配列番号13
5’-cggaattcatgagtaccatttatagggaga-3’
配列番号14
5’-cggtcgactgattaccaccatttatcata-3’
配列番号15
5’-cggagctcgagctgtgcaactcgagaca-3’
配列番号16
5’-ggactagttctttcttcaacaacgattgct-3’
SEQ ID NO:9
5'-ccggactagtaggagaacttctagtatatc-3'
SEQ ID NO:10
5'-ccggggatcctttctgacagagtaaaattc-3'
SEQ ID NO:11
5'-gccggatcccagttcgagtttatcattatc-3'
SEQ ID NO:12
5'-ggccgaattctttgtttgtttatgtgtgtt-3'
SEQ ID NO:13
5'-cggaattcatgagtaccatttatagggaga-3'
SEQ ID NO:14
5'-cggtcgactgattaccaccatttatcata-3'
SEQ ID NO:15
5'-cggagctcgagctgtgcaactcgagaca-3'
SEQ ID NO:16
5'-ggactagttctttcttcaacaacgattgct-3'
(2)HGT1強化株の作製
上記HGT1pr-LEU2-TDH3pr-HGT1プラスミドを制限酵素Xho Iで消化し、LEU2遺伝子が連結されたHGT1遺伝子の強発現カセットを得た。
サッカロマイセス・セレビシエBY4741(Mata his3Δ1 leu2Δ0 met15Δ0 ura3Δ0)を宿主にして当該発現カセットのダブルクロスオーバーの染色体相同組換えで、酢酸リチウム法を用いて形質転換を行った(図2)。目的とする染色体組換え株は、LEU2を選択マーカーとして、ロイシンを含まない選択培地(以降SD-leuと表記)に塗布しコロニー形成させることで選抜した。
形質転換体を新しいSD-leu寒天培地に線描してシングルコロニーアイソレーションしたのち、ロイシンを含まないSD液体培地に植菌して増殖させ、還元型グルタチオンを添加したSD寒天培地にスポットし、増殖しないこと、あるいは増殖遅延、を確認することでグルタチオンストレス感受性酵母の作製を確認した
(2) Preparation of HGT1 Enhanced Strain The above HGT1pr-LEU2-TDH3pr-HGT1 plasmid was digested with the restriction enzyme Xho I to obtain a strong expression cassette of the HGT1 gene linked with the LEU2 gene.
Saccharomyces cerevisiae BY4741 (Mata his3Δ1 leu2Δ0 met15Δ0 ura3Δ0) was transformed by double crossover chromosomal homologous recombination of the expression cassette using the lithium acetate method (Figure 2). The target chromosomal recombinant strain was selected by plating the LEU2 as a selection marker on a leucine-free selection medium (hereinafter referred to as SD-leu) and allowing it to form colonies.
The transformants were streaked on fresh SD-leu agar medium for single colony isolation, then inoculated into leucine-free SD liquid medium for growth, and spotted onto SD agar medium supplemented with reduced glutathione. The production of glutathione stress-sensitive yeast was confirmed by confirming that the transformants did not grow or that their growth was delayed.
(3)多コピーでグルタチオンストレスを抑圧する遺伝子のスクリーニング
前項(2)記載のグルタチオンストレス感受性酵母(HGT1強化株)に、サッカロマイセス・セレビシエの染色体から構築した3 gの酵母染色体ライブラリー(2μ URA3)を酢酸リチウム法で導入した。GSHを含む60枚のSD-leu-ura寒天培地に等量ずつ塗布し、一枚だけGSHを含まないSD-leu-ura寒天培地に塗布した。30℃で5日間インキュベーションしたところ、GSHを含まないSD-leu-ura寒天培地において約2,000個の形質転換体が得られた。よって60枚の、GSHを含むSD-leu-ura寒天培地でスクリーニングを実施したので、約120,000個の形質転換体を評価したことになる。
結果として3種類の酵母変異体に関して、グルタチオンストレス負荷環境でも良好な増殖性が観察された。これら酵母変異体から抽出した3種類のプラスミドについて、二種類プライマー(配列番号17と18)を用いてpRS426に挿入されているサッカロマイセス・セレビシエ染色体由来DNA塩基配列の一部を解読した。
(3) Screening of genes suppressing glutathione stress in multiple copies 3 g of a yeast chromosome library (2μ URA3) constructed from the chromosome of Saccharomyces cerevisiae was introduced into the glutathione stress-sensitive yeast (HGT1-enhanced strain) described in the previous section (2) by the lithium acetate method. Equal amounts of the library were spread on 60 SD-leu-ura agar plates containing GSH, and one SD-leu-ura agar plate not containing GSH. After incubation at 30° C. for 5 days, about 2,000 transformants were obtained on the SD-leu-ura agar plate not containing GSH. Thus, screening was performed on 60 SD-leu-ura agar plates containing GSH, which means that about 120,000 transformants were evaluated.
As a result, good growth was observed even in a glutathione stress environment for the three yeast mutants. For the three plasmids extracted from these yeast mutants, a part of the DNA base sequence derived from the Saccharomyces cerevisiae chromosome inserted into pRS426 was decoded using two primers (SEQ ID NOs: 17 and 18).
配列番号17
5’-taatacgactcactataggg-3’
配列番号18
5’-aattaaccctcactaaagg-3’
SEQ ID NO:17
5'-taatacgactcactataggg-3'
SEQ ID NO:18
5'-aattaaccctcactaaagg-3'
解読配列情報をSGD(Saccharomyces Genome Database)に照会したところ、染色体番号XIII(Chr III)、染色体番号V(Chr V)、染色体番号XV(Chr XV)、の染色体断片が挿入されていることが判明した。各染色体断片上に配座された遺伝子を以下に示す。
・染色体番号XIII(Chr III) : SIP5,RIM11,CIN4,
PSO2,GAT2
・染色体番号V(Chr V) : BMH1,PDA1,DMC1,ISC10
・染色体番号XV(Chr XV) : HIR2,CKB2,GLO4,CUE5,WHI2
When the decoded sequence information was checked against the Saccharomyces Genome Database (SGD), it was found that chromosome fragments of chromosome number XIII (Chr III), chromosome number V (Chr V), and chromosome number XV (Chr XV) had been inserted. The genes located on each chromosome fragment are shown below.
Chromosome number XIII (Chr III): SIP5, RIM11, CIN4,
PSO2, GAT2
・Chromosome number V (Chr V): BMH1, PDA1, DMC1, ISC10
Chromosome number XV (Chr XV): HIR2, CKB2, GLO4, CUE5, WHI2
これら遺伝子について、サッカロマイセス・セレビシエBY4741ゲノムを鋳型とし、pRS426ベクター上に単独でクローニングした。
上記DNA塩基配列を解析する手順と同様にしてpRS426ベクターに目的の遺伝子が単独で搭載されていることを確認した後、HGT1強化株に導入してグルタチオンストレス耐性の有無を評価することで、本スクリーニングで得られた計3種類の染色体断片それぞれについて、多コピーでグルタチオンストレスを抑圧する遺伝子、以下3種類を同定した(図3)。
・染色体番号XIII : RIM11
・染色体番号V : BMH1
・染色体番号XV : WHI2
These genes were cloned singly into the pRS426 vector using the Saccharomyces cerevisiae BY4741 genome as a template.
Using the same procedure as for analyzing the DNA base sequence described above, it was confirmed that the target gene was carried alone in the pRS426 vector, and then the vector was introduced into an HGT1-enhanced strain and the presence or absence of glutathione stress resistance was evaluated. In each of the three types of chromosomal fragments obtained in this screening, the following three types of genes that suppress glutathione stress in multiple copies were identified (Figure 3).
Chromosome number XIII: RIM11
・Chromosome number V: BMH1
・Chromosome number XV: WHI2
図3は、ネガティブコントロール(pRS426、ライブラリーのベクター)と、グルタチオンストレス耐性を示す3種類の変異体について、グルタチオンストレス感受性を比較したものである。
スポットの菌体濁度は左からOD600=2.5,0.25,0.025,0.0025,0.00025であり、各10 μlずつスポットし、30℃で3日間保持した。
FIG. 3 shows a comparison of glutathione stress sensitivity between the negative control (pRS426, library vector) and three mutants exhibiting glutathione stress resistance.
The turbidity of the spots was OD600 = 2.5, 0.25, 0.025, 0.0025, and 0.00025 from the left, and 10 μl of each was spotted and kept at 30° C. for 3 days.
[実施例2]
<RIM11強発現株の作製>
サッカロマイセス・セレビシエBY4741(Mata his3Δ1 leu2Δ0 met15Δ0 ura3Δ0)のゲノムDNAを鋳型にして、RIM11遺伝子(配列番号2)の、開始コドンから777塩基の領域を、二種類のプライマー(配列番号19と20)を用いてPCRで増幅させた。一方でTDH3prを二種類のプライマー(配列番号21と22)でPCR増幅させた。なお配列番号19と22のプライマーは互いに相補な15塩基配列を含むように合成した。
[Example 2]
<Preparation of strains strongly expressing RIM11>
Using the genomic DNA of Saccharomyces cerevisiae BY4741 (Mata his3Δ1 leu2Δ0 met15Δ0 ura3Δ0) as a template, a region of 777 bases from the initiation codon of the RIM11 gene (SEQ ID NO: 2) was amplified by PCR using two types of primers (SEQ ID NO: 19 and 20). Meanwhile, TDH3pr was amplified by PCR using two types of primers (SEQ ID NO: 21 and 22). The primers of SEQ ID NO: 19 and 22 were synthesized so as to contain 15 base sequences complementary to each other.
HIS3遺伝子を搭載した酵母-大腸菌シャトルベクターpRS303をSac IとBam HIで消化し、RIM11とTDH3pr、それぞれのPCR増幅産物と混合し、TaKaRa/Clontech製InFusion Cloning Kitを用いてツーピースライゲーションを行った。ライゲーション溶液で大腸菌を形質転換しアンピシリン耐性コロニーからプラスミド、TDH3pr-RIM11-pRS303を調製した。 The yeast-E. coli shuttle vector pRS303 carrying the HIS3 gene was digested with Sac I and Bam HI, mixed with the PCR amplified products of RIM11 and TDH3pr, and two-piece ligation was performed using the InFusion Cloning Kit manufactured by TaKaRa/Clontech. E. coli was transformed with the ligation solution, and the plasmid TDH3pr-RIM11-pRS303 was prepared from ampicillin-resistant colonies.
配列番号19
5’-acataaacaaacaaaatgaatattcaaagcaataattctc-3’
配列番号20
5’-gcagcccgggggatcctggagtacctaagattttaatg-3’
配列番号21
5’-tatagggcgaattggagctccagttcgagtttatcattatc-3’
配列番号22
5’-tttgtttgtttatgtgtgtttattc-3’
SEQ ID NO:19
5'-acataaacaaacaaaatgaatattcaaagcaataattctc-3'
SEQ ID NO:20
5'-gcagcccgggggatcctggagtacctaagattttaatg-3'
SEQ ID NO:21
5'-tatagggcgaattggagctccagttcgagtttatcattatc-3'
SEQ ID NO:22
5'-tttgtttgtttatgtgtgtttattc-3'
次に同ゲノムDNAをテンプレートとし、RIM11遺伝子のプロモーター領域(開始コドンの上流-961塩基から-48塩基まで、RIM11prと表記)を二種類のプライマー(配列番号23と24)を用いてPCRで増幅させた。TDH3pr-RIM11-pRS303をSal IとEco RIで切断し、上記と同じキットを用いてPCR増幅産物と連結し、RIM11pr-TDH3pr-RIM11-pRS303を得た(図4)。 Next, using the same genomic DNA as a template, the promoter region of the RIM11 gene (from bases -961 to -48 upstream of the start codon, designated RIM11pr) was amplified by PCR using two types of primers (SEQ ID NOs: 23 and 24). TDH3pr-RIM11-pRS303 was cut with Sal I and Eco RI, and ligated to the PCR amplified product using the same kit as above to obtain RIM11pr-TDH3pr-RIM11-pRS303 (Figure 4).
配列番号23
5’-ggccgaattcactaagtattatcaggaaac-3’
配列番号24
5’-ccaagtcgactaatgctatgtcaagatctt-3’
SEQ ID NO:23
5'-ggccgaattcactaagtattatcaggaaac-3'
SEQ ID NO:24
5'-ccaagtcgactaatgctatgtcaagatctt-3'
<GSH1強発現株の作製>
サッカロマイセス・セレビシエBY4741(Mata his3Δ1 leu2Δ0 met15Δ0 ura3Δ0)のゲノムDNAを鋳型にして、グルタチオン合成酵素-I遺伝子(GSH1)(アミノ酸配列:配列番号7、塩基配列:配列番号8)の翻訳領域開始コドンから1,118塩基までの領域を、二種類のプライマー(配列番号25と26)を用いてPCRで増幅させた。一方でTDH3prを二種類のプライマー(配列番号27と28)でPCR増幅させた。なお配列番号25と28のプライマーは互いに相補な15塩基配列(下線)が重複するように合成した。
<Preparation of a strain with strong GSH1 expression>
Using the genomic DNA of Saccharomyces cerevisiae BY4741 (Mata his3Δ1 leu2Δ0 met15Δ0 ura3Δ0) as a template, the region from the translation initiation codon to 1,118 bases of the glutathione synthetase-I gene (GSH1) (amino acid sequence: SEQ ID NO: 7, nucleotide sequence: SEQ ID NO: 8) was amplified by PCR using two types of primers (SEQ ID NOs: 25 and 26). Meanwhile, TDH3pr was PCR amplified using two types of primers (SEQ ID NOs: 27 and 28). The primers of SEQ ID NOs: 25 and 28 were synthesized so that their complementary 15-base sequences (underlined) overlap each other.
LEU2遺伝子を搭載した酵母-大腸菌シャトルベクターpRS305をSac IとBam HIで消化し、GSH1とTDH3pr、それぞれのPCR増幅産物と混合し、TaKaRa/Clontech製InFusion Cloning Kitを用いて2ピースライゲーションを行った。ライゲーション溶液で大腸菌を形質転換しアンピシリン耐性コロニーからプラスミド、TDH3pr-GSH1-pRS305を調製した。 The yeast-E. coli shuttle vector pRS305 carrying the LEU2 gene was digested with Sac I and Bam HI, mixed with the PCR amplified products of GSH1 and TDH3pr, and two-piece ligation was performed using the InFusion Cloning Kit manufactured by TaKaRa/Clontech. E. coli was transformed with the ligation solution, and the plasmid TDH3pr-GSH1-pRS305 was prepared from ampicillin-resistant colonies.
配列番号25
5’-acataaacaaacaaaatgggactcttagctttggg-3’
配列番号26
5’-gcagcccgggggatccttcgacccacccaagaaaag-3’
配列番号27
5’-tatagggcgaattggagctccagttcgagtttatcattatc-3’
配列番号28
5’-tttgtttgtttatgtgtgtttattc-3’
SEQ ID NO:25
5'-acataaacaaacaaaatgggactcttagctttggg-3'
SEQ ID NO:26
5'-gcagcccgggggatccttcgacccacccaagaaaag-3'
SEQ ID NO:27
5'-tatagggcgaattggagctccagttcgagtttatcattatc-3'
SEQ ID NO:28
5'-tttgtttgtttatgtgtgtttattc-3'
次に同ゲノムDNAをテンプレートとし、GSH1遺伝子のプロモーター領域(開始コドンの上流-1,000塩基から-441塩基まで、GSH1prと表記)を二種類のプライマー(配列番号29と30)を用いてPCRで増幅させた。
TDH3pr-GSH1-pRS305をSma IとXho Iで切断し、上記と同じキットを用いてPCR増幅産物と連結し、GSH1pr-TDH3pr-GSH1-pRS305を得た(図5)。PCR増幅配列についてはDNA塩基配列を解析することで例えば塩基置換や欠失、挿入等のエラーがないことを確認した。
Next, the promoter region of the GSH1 gene (from base -1,000 to base -441 upstream of the initiation codon, designated GSH1pr) was amplified by PCR using the same genomic DNA as a template and two types of primers (SEQ ID NOs: 29 and 30).
TDH3pr-GSH1-pRS305 was digested with Sma I and Xho I, and ligated to the PCR amplified product using the same kit as above to obtain GSH1pr-TDH3pr-GSH1-pRS305 (Figure 5). The PCR amplified sequence was analyzed for DNA base sequence to confirm the absence of errors such as base substitution, deletion, and insertion.
配列番号29
5’-aaggatcccccgggctgcaggctcatcacggaactgtaac-3’
配列番号30
5’-cgggccccccctcgagctccaactaccaaggttgt-3’
SEQ ID NO:29
5'-aaggatcccccgggctgcaggctcatcacggaactgtaac-3'
SEQ ID NO:30
5'-cgggccccccctcgagctccaactaccaaggttgt-3'
酢酸リチウム法を用いることにより、当該プラスミドでNco IとHind IIIで消化したGSH1過剰発現カセットで、サッカロマイセス・セレビシエBY4741(Mata his3Δ1 leu2Δ0 met15Δ0 ura3Δ0)を形質転換し、ロイシンを含まない選択培地SD-leuにスプレッドした。LEU2を選択マーカーとして、コロニー形成した株を選抜することで、GSH1強発現株(BY GSH1と表記する)を作製した。 Using the lithium acetate method, Saccharomyces cerevisiae BY4741 (Mata his3Δ1 leu2Δ0 met15Δ0 ura3Δ0) was transformed with the GSH1 overexpression cassette digested with Nco I and Hind III from the plasmid, and spread onto leucine-free selective medium SD-leu. A strain that formed colonies using LEU2 as a selection marker was selected to create a strain with strong GSH1 expression (designated BY GSH1).
前記のプラスミド、RIM11pr-TDH3pr-RIM11-pRS303(図4)を利用して、RIM11強発現DNA断片を、サッカロマイセス・セレビシエBY4741(Mata his3Δ1 leu2Δ0 met15Δ0 ura3Δ0)あるいは前記のBY GSH1に染色体相同組換えで導入した。 Using the above-mentioned plasmid, RIM11pr-TDH3pr-RIM11-pRS303 (Figure 4), the RIM11 strong expression DNA fragment was introduced into Saccharomyces cerevisiae BY4741 (Mata his3Δ1 leu2Δ0 met15Δ0 ura3Δ0) or the above-mentioned BY GSH1 by chromosomal homologous recombination.
前者についてはヒスチジンを含まない選択培地SD-hisにスプレッドした。HIS3を選択マーカーとして、コロニー形成した株を選抜することで、RIM11強発現株(BY RIM11と表記)を作製した。
後者についてはロイシンとヒスチジンを含まない選択培地SD-leu-hisにスプレッドした。LEU2とHIS3を選択マーカーとして、コロニー形成した株を選抜することで、GSH1強発現かつRIM11強発現株(BY GSH1 RIM11)を作製した。
The former was spread on a histidine-free selective medium SD-his. A strain that formed colonies using HIS3 as a selective marker was selected to prepare a strain that strongly expresses RIM11 (designated BY RIM11).
The latter was spread on a selective medium SD-leu-his not containing leucine or histidine. A strain that formed colonies using LEU2 and HIS3 as selective markers was selected to prepare a strain that strongly expresses GSH1 and RIM11 (BY GSH1 RIM11).
<グルタチオンストレス耐性酵母(RIM11強化株)のRNAシーケンス分析>
[実施例3]
(1)グルタチオンストレス耐性酵母、BY HGT1 RIM11の作出
実施例2記載のプラスミド、RIM11pr-TDH3pr-RIM11-pRS303(図4)を利用して、RIM11強発現DNA断片を、実施例1(2)記載のBY HGT1に染色体相同組換えで導入し、グルタチオンストレス耐性酵母、BY HGT1 RIM11、を作製した。
<RNA sequence analysis of glutathione stress-resistant yeast (RIM11-enhanced strain)>
[Example 3]
(1) Production of glutathione stress resistant yeast, BY HGT1 RIM11 Using the plasmid described in Example 2, RIM11pr-TDH3pr-RIM11-pRS303 ( FIG. 4 ), a RIM11 strong expression DNA fragment was introduced into BY HGT1 described in Example 1(2) by chromosomal homologous recombination to produce a glutathione stress resistant yeast, BY HGT1 RIM11.
(2)全RNAの調製
BY HGT1 RIM11株からホットフェノール法により全RNAを抽出した。以下に手順を示す。
10 mlのSDカザミノ酸培地(組成は実施例4に記載)に、OD600=0.25となるようにBY HGT1 RIM11前培養液を添加した。同じものを2本準備した。30℃でOD600=1まで振とう培養し、片方の培養液に還元型グルタチオン(GSH)を終濃度500 μMとなるように無菌的に添加し引き続き30℃で振とうさせた。
(2) Preparation of total RNA Total RNA was extracted from the BY HGT1 RIM11 strain by the hot phenol method. The procedure is as follows.
To 10 ml of SD Casamino Acid Medium (composition described in Example 4), BY HGT1 RIM11 preculture solution was added so that OD600 became 0.25. Two identical tubes were prepared. The culture was cultured with shaking at 30°C until OD600 became 1, and reduced glutathione (GSH) was aseptically added to one of the culture solutions to a final concentration of 500 μM, followed by shaking at 30°C.
GSH添加から2時間後、遠心分離で上清を除き酵母細胞を集め、即座に液体窒素に漬けて瞬間凍結した。65℃のTES Buffer(10 mM Tris-HCl(pH 7.5), 10 mM EDTA, 0.5% SDS)を500 μl加え、即座に、65℃の水飽和酸性フェノール(分子生物学用、和光純薬工業(製))、500 μlも添加しボルテックスで1分間はげしく混合させ、-20℃で保存した。 Two hours after the addition of GSH, the supernatant was removed by centrifugation, and the yeast cells were collected and immediately flash frozen by immersion in liquid nitrogen. 500 μl of 65°C TES buffer (10 mM Tris-HCl (pH 7.5), 10 mM EDTA, 0.5% SDS) was added, and 500 μl of 65°C water-saturated acidic phenol (for molecular biology, Wako Pure Chemical Industries, Ltd.) was immediately added, and the mixture was vigorously mixed with a vortex for 1 minute and stored at -20°C.
該-20℃保存サンプル(計2本)を65℃で30分間インキュベーションした。遠心分離して200 μlの上清を回収し、750 μlのトリゾールLS(インビトロジェン社製)を添加して混合し室温で5分間静置した。200 μlのクロロホルムを加え混合し、遠心分離操作により300 μlの上清を回収した後、500 μlのイソプロパノールを加えて混合した。 The -20°C stored samples (total of 2 samples) were incubated at 65°C for 30 minutes. After centrifugation, 200 μl of the supernatant was collected, and 750 μl of Trizol LS (Invitrogen) was added and mixed, and the mixture was left to stand at room temperature for 5 minutes. 200 μl of chloroform was added and mixed, and 300 μl of the supernatant was collected by centrifugation, after which 500 μl of isopropanol was added and mixed.
このうち沈殿含めた700 μlをRNeasy Mini Kit(QIAGEN)に供し、キット付属の標準手順書に則して精製し、RNaseフリー水で溶解して全RNA水溶液を得た。 700 μl of this, including the precipitate, was subjected to RNeasy Mini Kit (QIAGEN), purified according to the standard procedure included with the kit, and dissolved in RNase-free water to obtain a total RNA solution.
(3)ライブラリー調製
市販のキット、TruSeq RNA Sample Prep Kit v2(イルミナ社製)、を用いてライブラリーを作製した。
(3) Library Preparation A library was prepared using a commercially available kit, TruSeq RNA Sample Prep Kit v2 (Illumina).
(4)シーケンス解読
Illumina HiSeq 4000(イルミナ社製)を用い、上記cDNA断片の両端から100塩基ずつを解読した(ペアエンド法)。
TopHat(Bowtie aligner)を用いてサッカロマイセス・セレビシエのリファレンス、GCF_000146054.2、にマッピングした。
培養液にGSHを添加して2時間後に全RNAを抽出したサンプルを「GSH_posi_2hr」と表記し、左記と同時にサンプリングしたGSHを添加してない全RNA抽出サンプルを「GSH_nega_2hr」と表記する。
表1にRNAシーケンスにおけるトータルリード数とマッピングされたリード数、ならびにその割合、を示した。
(4) Sequencing Using Illumina HiSeq 4000 (manufactured by Illumina), 100 bases each from both ends of the cDNA fragment were decoded (paired-end method).
The sequence was mapped to the Saccharomyces cerevisiae reference, GCF_000146054.2, using TopHat (Bowtie aligner).
The sample in which total RNA was extracted 2 hours after the addition of GSH to the culture medium is denoted as "GSH_posi_2hr", and the total RNA extraction sample in which GSH was not added, sampled at the same time as the above, is denoted as "GSH_nega_2hr".
Table 1 shows the total number of reads and the number of mapped reads in RNA sequencing, as well as their percentages.
(5)データ解析
Cufflinksソフトウェアを用いて、「GSH_posi_2hr」と「GSH_nega_2hr」という二つの群間についてDEG(Differentially expressed genes)解析した。KEGG pathwayデータベース(http://www.genome.jp/kegg/pathway.html)より、統計的に有意な生物学的プロセスとしてMAPK経路や減数分裂、が抽出された。
(5) Data Analysis Using Cufflinks software, DEG (Differentially expressed genes) analysis was performed between the two groups, "GSH_posi_2hr" and "GSH_nega_2hr". From the KEGG pathway database (http://www.genome.jp/kegg/pathway.html), the MAPK pathway and meiosis were extracted as statistically significant biological processes.
<RIM11遺伝子発現強化株のグルタチオン生産>
[実施例4]
前記BY RIM11およびBY GSH1 RIM11株をSDカザミノ酸培地(1.7 g/L Yeast nitrogen base w/o Amino Acids and Ammonium Sulfate、2 g/L Vitamin Assay Casamino Acids(以上Difco laboratories社製)、5 g/L Ammonium Sulfate、20 g/L グルコース(以上和光純薬工業(株)製)、Adenine Sulfate 20 mg/L、Uracil 20 mg/L(以上Sigma Aldrich社製)、Tryptophan 20 mg/L(和光純薬工業(株)製))、10 mlで30℃、一晩振盪することにより種母培養を行った。
<Glutathione production in strains with enhanced RIM11 gene expression>
[Example 4]
The BY RIM11 and BY GSH1 RIM11 strains were grown in SD casamino acid medium (containing 1.7 g/L yeast nitrogen base with amino acids and ammonium sulfate, 2 g/L vitamin assay casamino acids (both manufactured by Difco laboratories), 5 g/L ammonium sulfate, 20 g/L glucose (both manufactured by Wako Pure Chemical Industries, Ltd.), 20 mg/L adenine sulfate, 20 mg/L uracil (both manufactured by Sigma Aldrich), 20 mg/L tryptophan, and 20 mg/L urea sulfate ... The seed culture was carried out in 10 ml of 10 mg/L (manufactured by Wako Pure Chemical Industries, Ltd.) at 30° C. overnight with shaking.
次に、上記と同じ組成の新しいSDカザミノ酸培地、10 mlを含むL字試験管にOD600=0.25となるように種母培養液を植菌し、30℃で撹拌60 rpmの条件で7時間培養を行い(このときの培養段階は対数増殖期)、培養液の一部をOD・Units=5[cm・ml]となるように遠心分離操作で回収した。残りは同じ条件で培養を継続し、種母培養液添加から18時間後(このときの培養段階は定常期)に培養液をOD・Units=5[cm・ml]となるように遠心分離機で回収した。 Next, the seed culture liquid was inoculated into an L-shaped test tube containing 10 ml of fresh SD Casamino Acids medium with the same composition as above to give an OD600 of 0.25, and cultured for 7 hours at 30°C with stirring at 60 rpm (the culture stage at this time was in the logarithmic growth phase), and a portion of the culture liquid was recovered by centrifugation to give an OD·Units=5 [cm·ml]. The remainder was continued to be cultured under the same conditions, and 18 hours after the addition of the seed culture liquid (the culture stage at this time was in the stationary phase), the culture liquid was recovered by centrifugation to give an OD·Units=5 [cm·ml].
[比較例1]
比較対象として、BY4741とBY GSH1も上記[実施例4]と同様の手順で培養し菌体を回収した。
[Comparative Example 1]
For comparison, BY4741 and BY GSH1 were also cultured in the same manner as in Example 4 above, and the cells were collected.
[実施例5]
<BY RIM11およびBY GSH1 RIM11のグルタチオン抽出液の調製>
菌体を0.1%W/Wの5-スルホサリチル酸水溶液(5-SSA)で二回洗浄し、80 μlの1%W/W 5-SSAを加え懸濁した。95℃で5分間熱処理して菌体内のグルタチオンを抽出し、冷却後、遠心分離して回収した上清を-20℃で保存した。当該抽出液を融解後、水で10倍希釈して0.1%W/W 5-SSA グルタチオン抽出液を調製した。該抽出液の総グルタチオン濃度はグルタチオンレダクターゼ-DTNB法(GR-DTNB法)で分析した。
[Example 5]
<Preparation of glutathione extracts of BY RIM11 and BY GSH1 RIM11>
The cells were washed twice with 0.1% w / w 5-sulfosalicylic acid (5-SSA) and suspended in 80 μl of 1% w / w 5-SSA. The cells were heat-treated at 95°C for 5 minutes to extract intracellular glutathione, cooled, centrifuged, and the collected supernatant was stored at -20°C. The extract was thawed and diluted 10-fold with water to prepare a 0.1% w / w 5-SSA glutathione extract. The total glutathione concentration of the extract was analyzed by the glutathione reductase-DTNB method (GR-DTNB method).
[比較例2]
<BY4741およびBY GSH1のグルタチオン抽出液の調製>
比較対象として、BY4741とBY GSH1、それぞれのグルタチオン抽出液を上記実施例5と同様の手順に従い調製した。
[Comparative Example 2]
<Preparation of glutathione extracts of BY4741 and BY GSH1>
For comparison, glutathione extracts of BY4741 and BY GSH1 were prepared according to the same procedure as in Example 5 above.
[実施例6]
<BY RIM11およびBY GSH1 RIM11抽出液の総グルタチオン分析>
実施例5で得たグルタチオン抽出液のうち、10 μlを分取して70 μlの5-SSA水溶液で希釈した。ここに以下組成の反応液を120 μl添加してマイクロプレートリーダーを用いて5分毎に3回、ODが420 nmの吸光度の変化を測定した。なお各サンプル三連で実施し、測定値はその平均値とした。
一方で、還元型グルタチオンの0.1%W/W5-SSA水溶液を準備し、0.1%W/W5-SSA水溶液で適宜希釈して段階的に濃度が異なるグルタチオン標準溶液を調製した。これらも三連で5分毎に3回、上述分析用サンプルと同時にOD420の吸光度を測定し、該数値差とグルタチオン濃度から検量線を描画した。
各分析サンプルの吸光度差の大きさと上記検量線、希釈倍率と抽出液量80 μlを乗することにより、OD・Units=5.0[cm・ml]におけるBY RIM11およびBY GSH1 RIM11抽出液中の総グルタチオン含量を算出した。
[Example 6]
<Total glutathione analysis of BY RIM11 and BY GSH1 RIM11 extracts>
10 μl of the glutathione extract obtained in Example 5 was taken and diluted with 70 μl of 5-SSA aqueous solution. 120 μl of the reaction solution with the following composition was added to this, and the change in absorbance at OD 420 nm was measured three times every 5 minutes using a microplate reader. Each sample was measured in triplicate, and the measured value was the average value.
On the other hand, a 0.1% w / w 5-SSA aqueous solution of reduced glutathione was prepared, and then diluted appropriately with the 0.1% w / w 5-SSA aqueous solution to prepare glutathione standard solutions with different concentrations. The OD420 absorbance was measured simultaneously with the above analytical samples, three times every 5 minutes, in triplicate, and a calibration curve was drawn from the difference in the values and the glutathione concentration.
The total glutathione content in the BY RIM11 and BY GSH1 RIM11 extracts at OD·Units=5.0 [cm·ml] was calculated by multiplying the magnitude of the absorbance difference between each analysis sample by the above-mentioned calibration curve, the dilution ratio, and the extract volume of 80 μl.
[比較例3]
<BY4741およびBY GSH1抽出液の総グルタチオン分析>
比較対照として、BY4741とBY GSH1、それぞれの総グルタチオン含量を上記実施例6と同様の手順で算出した。以上の結果を図6に示す。
[Comparative Example 3]
Total Glutathione Analysis of BY4741 and BY GSH1 Extracts
As a comparative control, the total glutathione content of BY4741 and BY GSH1 was calculated in the same manner as in Example 6. The results are shown in FIG.
GR-DTNB法の反応液の組成:
(1)リン酸カリウム緩衝液(pH 7.5)の調製
a) 0.1 M Potassium Dihydrogen Phosphate
b) 0.1 M Dipotassium Hydrogen Phosphate
a)とb)を混合してpH 7.5に調整した。
c)0.005 M EDTA・2Na・2H2O (同仁化学研究所製)
Composition of reaction solution for GR-DTNB method:
(1) Preparation of potassium phosphate buffer (pH 7.5) a) 0.1 M Potassium Dihydrogen Phosphate
b) 0.1 M Dipotassium Hydrogen Phosphate
a) and b) were mixed and the pH was adjusted to 7.5.
c) 0.005 M EDTA・2Na・2H 2 O (manufactured by Dojindo Laboratories)
(2)反応液の調製
前記リン酸カリウム緩衝液(pH 7.5)12 mlに対し2 mgのβ-NADPH(オリエンタル酵母工業製)と8 mgのDTNB(同仁化学研究所製)を添加して溶解後、グルタチオンレダクターゼ(オリエンタル酵母工業製)を1.2 μl添加した。反応液は分析前に用時調製した。
(2) Preparation of reaction solution 2 mg of β-NADPH (manufactured by Oriental Yeast Co., Ltd.) and 8 mg of DTNB (manufactured by Dojindo Laboratories) were added to 12 ml of the potassium phosphate buffer (pH 7.5) and dissolved, and then 1.2 μl of glutathione reductase (manufactured by Oriental Yeast Co., Ltd.) was added. The reaction solution was prepared just before analysis.
[実施例7]
<RIM11強化株、他の増殖性>
実施例4および比較例1で使用した3種類の変異体と、BY4741について、
種母培養液をOD600=0.1となるように新しいSDカザミノ酸培地に植菌し、30℃、70 rpm-1で振盪培養した。結果を図7に示す。
図7より、BY GSH1はBY4741(野生型)よりも増殖の立ち上がりが遅く、定常期の菌体数(バイオマス)も小さかった。一方でBY GSH1 RIM11はBY GSH1と比べて増殖速度と菌体数の点で、共に改善が見られた。
[Example 7]
<RIM11 enhanced strain, other proliferation properties>
Regarding the three types of mutants used in Example 4 and Comparative Example 1 and BY4741,
The seed culture was inoculated into fresh SD casamino acid medium to give an OD600 of 0.1, and cultured with shaking at 30° C. and 70 rpm −1 . The results are shown in FIG.
7, BY GSH1 showed a slower rise in growth rate and a smaller number of cells (biomass) in the stationary phase than BY4741 (wild type). On the other hand, BY GSH1 RIM11 showed improvements in both growth rate and number of cells compared to BY GSH1.
以上実施例6の図6と、実施例7の図7の結果より、グルタチオンストレス耐性を付与させることで、酵母のグルタチオン生産性を向上させることが出来ることを確認した。 From the results shown in Figure 6 of Example 6 and Figure 7 of Example 7, it was confirmed that glutathione productivity of yeast can be improved by imparting glutathione stress resistance.
[実施例8]
RIM11遺伝子、IME1遺伝子、ならびにUME6遺伝子破壊株(OpenBiosystems社製)、それぞれを実施例1記載のグルタチオントランスポーターHGT1強発現用カセットで形質転換した。LEU2を選択マーカーとして、SD-leuに塗布しコロニー形成させることで選抜した。このようにしてΔrim11 HGT1、Δime1 HGT1、ならびにΔume6 HGT1を得た。
図8より、Δume6 HGT1はグルタチオンストレス高感受性に陥ったことから、Ume6が酵母にグルタチオンストレス耐性の付与に関与することが新規に判明した。
[Example 8]
The RIM11 gene, IME1 gene, and UME6 gene disrupted strains (manufactured by OpenBiosystems) were each transformed with the cassette for strong expression of glutathione transporter HGT1 described in Example 1. LEU2 was used as a selection marker, and the strains were selected by plating on SD-leu and forming colonies. In this way, Δrim11 HGT1, Δime1 HGT1, and Δume6 HGT1 were obtained.
As shown in FIG. 8, Δume6 HGT1 became highly sensitive to glutathione stress, which revealed that Ume6 is involved in imparting glutathione stress resistance to yeast.
[実施例9]
図9記載の各変異体をSDカザミノ酸液体培地中に菌体濁度OD600=0.1となるように植菌し、30℃、70 rpm-1で振とう培養した。
図9より、グルタチオンストレス誘導条件(with GSH)でΔrim11 HGT1とΔume6 HGT1の増殖性が著しく低下した。上記[実施例8]の結果も併せて、Rim11とUme6がグルタチオンストレス耐性の発現に機能することが確認された。
[Example 9]
Each of the mutants shown in FIG. 9 was inoculated into SD casamino acid liquid medium to a bacterial cell turbidity of OD600=0.1, and cultured at 30° C. and 70 rpm −1 with shaking.
9, the proliferation ability of Δrim11 HGT1 and Δume6 HGT1 was significantly decreased under glutathione stress-inducing conditions (with GSH). Together with the results of [Example 8] above, it was confirmed that Rim11 and Ume6 function in expressing glutathione stress resistance.
[実施例10]
上記実施例8で、対象とする酵母菌株をSIN3遺伝子破壊株(OpenBiosystems社製)にしたこと以外は、実施例8記載の方法に順ずる。このようにして
Δsin3 HGT1を得た。配列番号31と32に記載の二種類のプライマーを用い、pRS306(URA3)を鋳型にしてURA3遺伝子をPCR増幅した。該増幅産物でΔsin3 HGT1を形質転換し、SD-Ura寒天培地に塗布した。RPD3遺伝子の翻訳領域がPCR増幅産物で組換えられ、遺伝子機能が破壊されたΔrpd3Δsin3 HGT1を、URA3遺伝子を選択マーカーとして選抜した。
図10のスポットアッセイは、実施例8に記載の方法と同様に行った。
図10より、Δsin3 HGT1のグルタチオン感受性はBY HGT1よりも大きく、Δrpd3Δsin3 HGT1では、より高感受性だった。
以上、実施例8~10の結果より、エピジェネティクス機構で互いに協調して機能するUme6、RPD3、SIN3が、酵母にグルタチオンストレス耐性を付与する際に重要であることが明らかになった。
[Example 10]
The method described in Example 8 above was followed, except that the yeast strain of interest was a SIN3 gene disruptant (manufactured by OpenBiosystems). In this manner, Δsin3 HGT1 was obtained. Using two types of primers described in SEQ ID NOs: 31 and 32, the URA3 gene was PCR amplified using pRS306 (URA3) as a template. Δsin3 HGT1 was transformed with the amplified product and spread on SD-Ura agar medium. Δrpd3Δsin3 HGT1, in which the translation region of the RPD3 gene had been recombined with the PCR amplified product and gene function had been disrupted, was selected using the URA3 gene as a selection marker.
The spot assay in FIG. 10 was carried out in a similar manner to that described in Example 8.
As shown in FIG. 10, Δsin3 HGT1 had a higher glutathione sensitivity than BY HGT1, and Δrpd3Δsin3 HGT1 was even more sensitive.
As described above, the results of Examples 8 to 10 demonstrated that Ume6, RPD3, and SIN3, which function in coordination with each other in the epigenetic mechanism, are important in conferring glutathione stress resistance to yeast.
配列番号31
5’-caattgcgccatacaaaacattcgtggctacaactcgatatccgtgcagcttaactatgcggcatcagag-3’
配列番号32
5’-atgtaaataacacatataggcaattttcttcgaaacgtatgggacgcggtcctgatgcggtattttctcc-3’
SEQ ID NO:31
5'-caattgcgccatacaaaacattcgtggctacaactcgatatccgtgcagcttaactatgcggcatcagag-3'
SEQ ID NO:32
5'-atgtaaataacacatataggcaattttcttcgaaacgtatgggacgcggtcctgatgcggtattttctcc-3'
Claims (3)
(a)Mitogen activated-protein kinase(MAPK)経路
(b)減数分裂
(A)配列番号1のアミノ酸配列と90%以上の同一性を有するアミノ酸配列
(B)配列番号2のアミノ酸配列と90%以上の同一性を有するアミノ酸配列
(C)配列番号3のアミノ酸配列と90%以上の同一性を有するアミノ酸配列 A method for producing glutathione, comprising: a gene belonging to the biological process (a) or (b) below is a DNA encoding any one of the amino acid sequences (A) to (C) below, the yeast being obtained by transforming a parent strain with the gene; and the yeast having improved glutathione stress resistance compared to the parent strain being cultured in the presence of glutathione to an extent that the parent strain of the yeast does not grow or grows slowly under glutathione stress.
(a) Mitogen-activated protein kinase (MAPK) pathway (b) Meiosis (A) An amino acid sequence having 90 % or more identity with the amino acid sequence of SEQ ID NO:1 (B) An amino acid sequence having 90 % or more identity with the amino acid sequence of SEQ ID NO:2 (C) An amino acid sequence having 90 % or more identity with the amino acid sequence of SEQ ID NO:3
(I)エピジェネティクス機構
(D)配列番号33のアミノ酸配列と90%以上の同一性を有するアミノ酸配列
(E)配列番号34のアミノ酸配列と90%以上の同一性を有するアミノ酸配列
(F)配列番号35のアミノ酸配列と90%以上の同一性を有するアミノ酸配列 (a) A method for producing glutathione, comprising: culturing a yeast obtained by transforming a parent strain with DNA encoding any one of the amino acid sequences (D) to (F) below among genes belonging to the mechanism (I) below, which is a biological process that functions downstream of the MAPK pathway and which transitions the cell division stage to somatic cell division or meiosis, or to a temporary pause in division (G1 arrest, G2 arrest) as appropriate in response to changes in the external growth environment, and which has improved glutathione stress resistance compared to the parent strain, in the presence of glutathione to an extent that the parent strain of the yeast does not grow or grows slowly under glutathione stress.
(I) epigenetic mechanism (D) an amino acid sequence having 90 % or more identity with the amino acid sequence of SEQ ID NO: 33 (E) an amino acid sequence having 90 % or more identity with the amino acid sequence of SEQ ID NO: 34 (F) an amino acid sequence having 90 % or more identity with the amino acid sequence of SEQ ID NO: 35
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2017113420 | 2017-06-08 | ||
| JP2017113420 | 2017-06-08 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018201508A JP2018201508A (en) | 2018-12-27 |
| JP7620382B2 true JP7620382B2 (en) | 2025-01-23 |
Family
ID=64954416
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018109210A Active JP7620382B2 (en) | 2017-06-08 | 2018-06-07 | Glutathione stress resistant yeast |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP7620382B2 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102354283B1 (en) * | 2020-04-03 | 2022-01-21 | 씨제이제일제당 주식회사 | A novel promoter and method of producing glutathione using thereof |
-
2018
- 2018-06-07 JP JP2018109210A patent/JP7620382B2/en active Active
Non-Patent Citations (5)
| Title |
|---|
| Eur.J.Biochem.,1995,Vol.229,pp.45-53 |
| FEBS Lett.,1992,Vol.302,No.2,pp.145-150 |
| Genetics,2017.05.02,Vol.206,pp.829-842 |
| J.Gen.Microbiol.,1985,Vol.131,pp.1797-1806 |
| Mol.Cell.Biol.,1990,Vol.10,No.11,pp.5927-5936 |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2018201508A (en) | 2018-12-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Takagi | Molecular mechanisms and highly functional development for stress tolerance of the yeast Saccharomyces cerevisiae | |
| AU2011200187B2 (en) | Mutant AOX 1 Promoters | |
| KR102253479B1 (en) | Promoter variant | |
| JP2022025068A (en) | Expression constructs and methods of genetically engineering methylotrophic yeast | |
| Gassler et al. | Adaptive laboratory evolution and reverse engineering enhances autotrophic growth in Pichia pastoris | |
| Yanagida et al. | The evolutionary potential of phenotypic mutations | |
| US20100297738A1 (en) | Expression system | |
| Zocchi | Metabolic changes in iron-stressed dicotyledonous plants | |
| TW201317350A (en) | Regulatable promoter | |
| Wei et al. | Quantitative characterization of filamentous fungal promoters on a single-cell resolution to discover cryptic natural products | |
| Fang et al. | MdMYB110a, directly and indirectly, activates the structural genes for the ALA-induced accumulation of anthocyanin in apple | |
| Hou et al. | Analysis of salt-tolerance genes in Zygosaccharomyces rouxii | |
| JP7620382B2 (en) | Glutathione stress resistant yeast | |
| US11873517B2 (en) | Candida tropicalis strain having improved tolerance to the cytotoxicity of substrates, and method for producing dicarboxylic acid using same | |
| Ferreyra et al. | A yeast sterol carrier protein with fatty-acid and fatty-acyl-CoA binding activity | |
| Srikanth et al. | Multiple cis-regulatory elements and the yeast sulphur regulatory network are required for the regulation of the yeast glutathione transporter, Hgt1p | |
| Khanal et al. | Role for nitrate assimilatory genes in virulence of Ustilago maydis | |
| Rebnegger et al. | Knock-out of the major regulator Flo8 in Komagataella phaffii results in unique host strain performance for methanol-free recombinant protein production | |
| Wang et al. | Enhancing abscisic acid production in Botrytis cinerea through metabolic engineering based on a constitutive promoter library | |
| DE102011056290A1 (en) | MUSHROOMS WITH GENETIC MODIFICATION CONCERNING A CARBONIC ACID TRANSPORTER | |
| Qi et al. | Transcription factor Pofst3 regulates Pleurotus ostreatus development by targeting multiple biological pathways | |
| Kafasla et al. | The proline permease of Aspergillus nidulans: functional replacement of the native cysteine residues and properties of a cysteine-less transporter | |
| WO2023204107A1 (en) | Yeast strain for the production of jasmonic acid | |
| Zheng et al. | Characterisation of a mitochondrial iron transporter of the pathogen Trypanosoma brucei | |
| Dey et al. | Post-transcriptional regulation of glutamate metabolism of Pichia pastoris and development of a glutamate-inducible yeast expression system |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20210604 |
|
| A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A712 Effective date: 20210604 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20220330 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20220419 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220620 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20221101 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230131 |
|
| C60 | Trial request (containing other claim documents, opposition documents) |
Free format text: JAPANESE INTERMEDIATE CODE: C60 Effective date: 20230131 |
|
| A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20230207 |
|
| C21 | Notice of transfer of a case for reconsideration by examiners before appeal proceedings |
Free format text: JAPANESE INTERMEDIATE CODE: C21 Effective date: 20230215 |
|
| A912 | Re-examination (zenchi) completed and case transferred to appeal board |
Free format text: JAPANESE INTERMEDIATE CODE: A912 Effective date: 20230224 |
|
| C211 | Notice of termination of reconsideration by examiners before appeal proceedings |
Free format text: JAPANESE INTERMEDIATE CODE: C211 Effective date: 20230228 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240805 |
|
| R155 | Notification before disposition of declining of application |
Free format text: JAPANESE INTERMEDIATE CODE: R155 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20250110 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7620382 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |